<DOC>
	<DOCNO>NCT00944320</DOCNO>
	<brief_summary>Polymorphisms occur several gene encode key enzyme folate pathway may affect drug metabolism patient rheumatoid arthritis . Whether genetic variation contribute differential response antifolate drug patient rheumatoid arthritis ( RA ) remain investigated Taiwanese population . Objective . The goal present study investigate interaction genetic variation folate gene efficacy/side effect anti-folate disease-modifying antirheumatic drug Taiwan . DESIGN . A cross-sectional study involve 100 patient RA enrol TCVGH . Genotypes methylenetetrahydrofolate reductase ( MTHFR677C &gt; T ) , tandem repeat polymorphism thymidylate synthase enhancer region ( TSER ) folylpoly-gamma-glutamate synthetase ( FPGS1901T &gt; C ) determine RFLP pyrosequencing .</brief_summary>
	<brief_title>Pharmacogenetics Antifolate Disease Modifying Anti-Rheumatic Drugs Rheumatoid Arthritis Taiwan</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Antirheumatic Agents</mesh_term>
	<criteria>Male/female age &gt; 18 Clinical diagnosis Rheumatoid Arthritis Must pregnant/breastfeeding Other condition may lead exclusion trial ( e.g . Diabetes mellitis , malignant melanoma , cardiac conduction disorder , hepatic/renal insufficiency .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>